PLECOID
LIVE

Serial Number

79306239

Owner

Pleco Therapeutics B.V.

Attorney

Thomas D. Bratschun

Filing Date

Jan 4, 2021

Add to watchlist:

No watchlists yet
View on USPTO

PLECOID Trademark

Serial Number: 79306239 • Registration: 6733742

PLECOID is a trademark filed by Pleco Therapeutics B.V. on January 4, 2021. The trademark is classified under Class 1 (Chemicals), Class 5 (Pharmaceuticals), Class 44 (Medical Services). The application is currently registered and active.

Owner Contact Info

Pleco Therapeutics B.V.

Jonkerbosplein 52

Entity Type: 99

Trademark Details

Filing Date

January 4, 2021

Registration Date

May 24, 2022

Published for Opposition

March 8, 2022

Goods & Services

Pharmaceuticals for the treatment of viral infections; pharmaceuticals for the treatment of cardiovascular disorders and conditions; pharmaceuticals for the treatment of neurological diseases and disorders; pharmaceuticals for the treatment of respiratory disorders and conditions; pharmaceuticals for the treatment of fungal diseases and disorders; pharmaceuticals for the treatment of liver disease; pharmaceuticals for the treatment of HIV/AIDS and hepatitis; pharmaceuticals for the treatment of inflammatory diseases and disorders; pharmaceuticals for the treatment of cancer; pharmaceutical preparations for immunotherapy, including t cell therapy

Chemicals for use in science, scientific research and for laboratory use; analytical and diagnostic reagents for in vitro use for scientific and research purposes

Providing health and medical information about medical disorders and their diagnosis, prevention and treatment; counselling and charitable services for patients, namely, providing medical information and assistance with respect to obtaining prescription medications; medical consultation, namely, providing advice to healthcare professionals regarding medical disorders and their diagnosis, prevention and treatment; providing medical information; providing medical information regarding treatment, prevention, and diagnosis of medical conditions; medical information and advisory services relating to pharmaceuticals, diseases and medical conditions and treatment, including such services provided on-line from a computer network or the Internet

Filing History

FINAL DECISION TRANSACTION PROCESSED BY IB
Oct 2, 2022 FINO
FINAL DISPOSITION NOTICE SENT TO IB
Sep 14, 2022 FICS
FINAL DISPOSITION PROCESSED
Sep 14, 2022 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Aug 24, 2022 FICR
NOTICE OF REGISTRATION CONFIRMATION EMAILED
May 24, 2022 NRCC
REGISTERED-PRINCIPAL REGISTER
May 24, 2022 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Mar 8, 2022 NPUB
PUBLISHED FOR OPPOSITION
Mar 8, 2022 PUBO
NOTIFICATION PROCESSED BY IB
Mar 7, 2022 GPNX
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Feb 16, 2022 OPNS
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Feb 16, 2022 OP2R
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Feb 16, 2022 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Feb 2, 2022 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Jan 21, 2022 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jan 20, 2022 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jan 20, 2022 TROA
REFUSAL PROCESSED BY IB
Aug 8, 2021 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Jul 22, 2021 RFCS
REFUSAL PROCESSED BY MPU
Jul 22, 2021 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Jul 14, 2021 RFCR
NON-FINAL ACTION WRITTEN
Jul 13, 2021 CNRT
ASSIGNED TO EXAMINER
Jul 13, 2021 DOCK
CHANGE OF NAME/ADDRESS REC'D FROM IB
May 21, 2021 ADCH
APPLICATION FILING RECEIPT MAILED
Mar 16, 2021 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Mar 12, 2021 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Mar 11, 2021 REPR